MedAssets Reports Second Quarter and Six-Month 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Leerink Raises Price Target on MedAssets (MDAS) Following 2Q EPS Beat
July 30, 2015 10:32 AM EDTLeerink Partners reiterated a Market Perform rating on MedAssets (NASDAQ: MDAS), and raised the price target to $22.00 (from $21.00), following 2Q15 results. MDAS reported 2Q total revenue of $190.4M, ahead consensus of $187.3M. Adjusted EPS of $0.31 was also ahead of consensus of $0.27.
Analyst David Larsen commented, "This afternoon... More
MedAssets (MDAS) Tops Q2 EPS by 4c; Guides FY15 EPS Above Consensus
July 29, 2015 4:37 PM EDTMedAssets (NASDAQ: MDAS) reported Q2 EPS of $0.31, $0.04 better than the analyst estimate of $0.27. Revenue for the quarter came in at $190.4 million versus the consensus estimate of $187.45 million.
MedAssets sees FY2015 EPS of $1.20-$1.26, versus the consensus of $1.19. MedAssets sees FY2015 revenue of $756-768... More
